CHARLES TOWN, W.Va., April 9 /PRNewswire/ -- ReBuilder Medical Technologies, Inc. , President/CEO, David B. Phillips, Ph.D., today announced that they have rejected an offer to merge with an OTC traded company.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)
“We are going to stick to our guns. Although the value assigned to us by the OTC Company was a significant multiple over our current valuation, we feel that we should investigate a single jump, rather than one move to the bulletin board and then to the NASDAQ. We are moving toward meeting the requirements of participation in the NASDAQ, but would welcome offers to merge with an already listed NASDAQ company because it would fast track that process. Each of these projects takes time away from developing our core business and we plan to focus on building our sales and market share rather than spending too much time in administrative negotiations,” says David B. Phillips, Ph.D., CEO.
For more information visit: www.rebuildermedical.com and www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,
+1-304-725-2202
Web site: http://www.molluscum.com/
http://www.rebuildermedical.com/
